ReviewJournal of clinical medicine2023

Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: New Approved Options.

Alejandro Martín García-Sancho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.